Clinical Trial

COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective cohort study of COVID-19 infection among children in Norway.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-04-03; most recent amendment 2022-02-14.
Status change: Not Yet Recruiting → Recruiting 2020-04-16
Trial Details
NCT Number NCT04335773
Lead Sponsor University Hospital, Akershus
Collaborators: St. Olavs Hospital, Helse Stavanger HF, Haukeland University Hospital, University Hospital of North Norway, Alesund Hospital, Norwegian Institute of Public Health, The University of New South Wales, University of Bristol, Sykehuset Ostfold, Nordlandssykehuset HF, Vestre Viken Hospital Trust, Helse Fonna, Helse Nord-Trøndelag HF, Oslo University Hospital, Sykehuset Innlandet HF
Conditions Pediatric Respiratory Diseases, COVID, Fatigue Post Viral
Enrollment 350 participants
Start Date 2020-04-03
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-02-16